This wiki is available to document the progress of the PhUSE project "Therapeutic Areas".
The wiki enables quick,easy and transparent online collaboration of the different project teams.
Each indication has a main page (each listed below).
This is the starting page for all project team activity.
Project teams should add pages and topics as necessary.
Ideally, all collaboration would take place through the wiki, and email will be limited.
If you are new to wikis you might want to check out the help section.
To get started click on your project team below.
PhUSE Indication Project Teams
The goal of this project is
To increase the awareness of therapeutical area specific knowledge relevant for Statistical Programmers, Statisticians and Data Managers
The project has the following objectives
- to prepare Wikis with comprehensive indication specific information related to
- Description of Disease
- Agency Guidelines applicable for the corresponding Disease or Indication
- Clinical Trial Endpoints
- Clinical Trial Designs
- Data Collection
- Data Challenges
- SDTM Data
- ADaM Data
- Statistical Analysis
- to review and maintain information provided on indication specific Wikis
- to facilitate a Discussion Club/Workshop at the annual PhUSE conference in 2013
Working Group Meetings
The working group on Therapeutic Areas meets regular to discuss the status and progress of the single therapeutic areas.
You can find the minutes here:
PhUSE Wiki TC 02092013: PhUSE_Wiki_TC_02092013
TC 30092013: PhUSE_Wiki_TC_30092013
TA Project Team: Slides Kick-off Meeting Media:PhUSE 2013-TA workshops-draft.pdf
| The information contained in this Indication specific Wiki is based on research of personal PhUSE Wiki authors.
PhUSE Wiki authors may or may not be experts in the field of the specific disease.
Neither PhUSEwiki.org nor the PhUSE guarantee for the correctness of the displayed information.
This section might need additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.